11:26 AM EDT, 05/08/2024 (MT Newswires) -- European equities traded in the US as American depositary receipts were trending modestly higher late Wednesday morning, rising 0.34% to 1,399.71 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by brewing company Anheuser-Busch InBev ( BUD ) and kidney dialysis company Fresenius Medical Care ( FMS ) , which rose 4.5% and 3.2%, respectively. They were followed by biopharmaceutical firms Genfit ( GNFT ) and Grifols ( GRFS ) , which increased 2.3% and 2%, respectively.

The decliners from continental Europe were led by semiconductor company Sequans Communications ( SQNS ) and hotel booking site trivago (TRVG), which lost 7.7% and 3.6% respectively. They were followed by biopharmaceutical company Calliditas Therapeutics ( CALT ) and telecommunications operator Telefonica ( TEF ) , which were down 2% and 1.9% respectively.

From the UK and Ireland, the gainers were led by biopharmaceutical companies Akari Therapeutics ( AKTX ) and NuCana ( NCNA ) , which climbed 7% and 4.1% respectively. They were followed by biopharmaceutical company Biodexa Pharmaceuticals ( BDRX ) and biotech firm Autolus Therapeutics ( AUTL ) , which were up 3.9% and 2.1% respectively.

The decliners from the UK and Ireland were led by pharmaceutical company Avadel Pharmaceuticals ( AVDL ) and biopharmaceutical company Adaptimmune Therapeutics ( ADAP ) , which fell 8.4% and 3.6% respectively. They were followed by biopharmaceutical company Amarin ( AMRN ) and construction materials supplier CRH (CRH), which lost 2.6% and 1.2% respectively.